BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10485075)

  • 1. MR imaging of pancreatic lesions. Comparison of manganese-DPDP and gadolinium chelate.
    Diehl SJ; Lehmann KJ; Gaa J; McGill S; Hoffmann V; Georgi M
    Invest Radiol; 1999 Sep; 34(9):589-95. PubMed ID: 10485075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance with manganese-DPDP (mangafodipir) of focal solid pancreatic lesions.
    Zanello A; Nicoletti R; Brambilla P; Boccuni R; Di Carlo V; Staudacher C; Del Maschio A
    Radiol Med; 2004 Sep; 108(3):194-207. PubMed ID: 15343134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate.
    Kettritz U; Warshauer DM; Brown ED; Schlund JF; Eisenberg LB; Semelka RC
    Eur Radiol; 1996; 6(1):14-8. PubMed ID: 8797944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience.
    Gehl HB; Urhahn R; Bohndorf K; Klever P; Hauptmann S; Lodemann KP; Matern S; Schumpelick V; Günther RW
    Radiology; 1993 Mar; 186(3):795-8. PubMed ID: 8430190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced MR imaging of the pancreas.
    Kettritz U; Semelka RC
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):87-100. PubMed ID: 8673719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mn-DPDP enhanced MR imaging of the liver: analysis of pulse sequence performance.
    Slater GJ; Saini S; Mayo-smith WW; Sharma P; Eisenberg PJ; Hahn PF
    Clin Radiol; 1996 Jul; 51(7):484-6. PubMed ID: 8689823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results.
    Kettritz U; Schlund JF; Wilbur K; Eisenberg LB; Semelka RC
    Magn Reson Imaging; 1996; 14(10):1185-90. PubMed ID: 9065909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of exocrine cells in pancreatic enhancement using Mn-DPDP-enhanced MR imaging.
    Gong J; Xu J; Zhou K; Shen K
    Chin Med J (Engl); 2002 Sep; 115(9):1363-6. PubMed ID: 12411113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
    Rofsky NM; Earls JP
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic enhancement and pulse sequence analysis using low-dose mangafodipir trisodium.
    Mayo-Smith WW; Schima W; Saini S; Slater GJ; McFarland EG
    AJR Am J Roentgenol; 1998 Mar; 170(3):649-52. PubMed ID: 9490946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical value of Mn-DPDP: a new paramagnetic hepatobiliary contrast medium for magnetic resonance tomography of the liver].
    Vogl TJ; Hamm B; Schnell B; Eibl-Eibesfeldt B; Steiner S; Lissner J
    Rofo; 1991 Dec; 155(6):568-74. PubMed ID: 1764599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI with mangafodipir trisodium in the detection of pancreatic tumours: comparison with helical CT.
    Rieber A; Tomczak R; Nüssle K; Klaus H; Brambs HJ
    Br J Radiol; 2000 Nov; 73(875):1165-9. PubMed ID: 11144793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mn-DPDP enhancement patterns of hepatocellular lesions on MR images.
    Vogl TJ; Hamm B; Schnell B; McMahon C; Branding G; Lissner J; Wolf KJ
    J Magn Reson Imaging; 1993; 3(1):51-8. PubMed ID: 8381314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mangafodipir trisodium-enhanced MR imaging of pancreatic disease.
    Boraschi P; Donati F; Gigoni R; Caramella D; Boggi U; Falaschi F; Bartolozzi C
    Eur Radiol; 2006 May; 16(5):988-97. PubMed ID: 16421713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
    Murakami T; Baron RL; Peterson MS; Oliver JH; Davis PL; Confer SR; Federle MP
    Radiology; 1996 Jul; 200(1):69-77. PubMed ID: 8657947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology.
    Marchal G; Zhang X; Ni Y; Van Hecke P; Yu J; Baert AL
    Magn Reson Imaging; 1993; 11(5):665-74. PubMed ID: 8345781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
    Hamm B; Vogl TJ; Branding G; Schnell B; Taupitz M; Wolf KJ; Lissner J
    Radiology; 1992 Jan; 182(1):167-74. PubMed ID: 1309218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Manganese DPDP as a contrast medium for MR tomography of focal liver lesions. Tolerance and image quality in 20 patients].
    Kopp AF; Laniado M; Aicher KP; Grönewäller EF; Claussen CD
    Rofo; 1992 Dec; 157(6):539-47. PubMed ID: 1457788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MR imaging of pancreatic lesions with Mn-DPDP. A histopathologic correlation].
    Dobritz M; Fellner FA; Baum U; Nömayr A; Lell M; Klein P; Papadopoulos T; Bautz W
    Rofo; 2002 Jul; 174(7):893-7. PubMed ID: 12101481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.